Bevacizumab and Platinum Choice in Pembrolizumab-Treated Advanced Cervical Cancer - Top-Institutions - MDSpire

Bevacizumab and Platinum Choice in Pembrolizumab-Treated Advanced Cervical Cancer

  • By

  • Alberto Farolfi

  • Chiara Casadei

  • Emanuela Scarpi

  • Eleonora Paoletti

  • Caterina Gianni

  • Michela Palleschi

  • Nicola Gentili

  • Marita Mariotti

  • Sara Testoni

  • Giandomenico Di Menna

  • Francesca Rusconi

  • Alice Andalò

  • Olga Serra

  • Filippo Merloni

  • Marianna Sirico

  • Roberta Maltoni

  • Lorenzo Cecconetto

  • Samanta Sarti

  • Antonino Musolino

  • July 14, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology

  • #2

    Gynecologic Oncology Center
    Gynecologic Oncology Center

    Kiel, Germany

    Key Differentiators

    • Gynecologic Oncology

  • #3

    TriNetX Global Collaborative Network
    TriNetX Global Collaborative Network

    Cambridge, MA

    Key Differentiators

    • Data Analytics
    • Oncology

  • #4

    HonorHealth Research Institute
    HonorHealth Research Institute

    Scottsdale, AZ

    Key Differentiators

    • Oncology

  • #5

    University of Arizona College of Medicine
    University of Arizona College of Medicine

    Tucson, AZ

    Key Differentiators

    • Oncology

Original Source(s)

Bevacizumab and Platinum Choice in Pembrolizumab-Treated Advanced Cervical Cancer

  • by Alberto Farolfi, Chiara Casadei, Emanuela Scarpi, Eleonora Paoletti, Caterina Gianni, Michela Palleschi, Nicola Gentili, Marita Mariotti, Sara Testoni, Giandomenico Di Menna, Francesca Rusconi, Alice Andalò, Olga Serra, Filippo Merloni, Marianna Sirico, Roberta Maltoni, Lorenzo Cecconetto, Samanta Sarti, Antonino Musolino

  • July 14, 2026

Related Content

A staged adoption pathway for intraoperative imaging in brain tumor surgery: cost-effectiveness and accessibility in resource-limited neurosurgical settings

T cell-mediated immune function in gastric cancer: a bibliometric overview of the last 20 years (2006-2025)

A hybrid ViT-L/32–MaxViT-L architecture with adaptive gated fusion for multiclass gastrointestinal disease detection and multi-method post-hoc explainability